Open Source Drug Discovery

Open Source Drug Discovery

Open Source Drug Discovery is a Council of Scientific and Industrial Research, India-led Team India Consortium with global participation offering a collaborative drug discovery platform for neglected tropical diseases like leishmaniasis, which draw limited attention of research-based pharmaceutical enterprises. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Open Source Drug Discovery, India, covering academic research published from 2001 to 2024. Read More.


Open Access Percentage

57%


Total
Publications

129


Total Open
Publications

73


Total
Citations

2K


Open Access
Percentage

57%


Total
Publications

129


Total Open
Publications

73


Total
Citations

2K

Wikipedia

Website

download

Breakdown

25% 29% 3% 43%

Publisher Open

25%

Both

29%

Other Platform Open

3%

Closed

43%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

024681012141618Total Publications
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

42%OA Journal

OA Journal 42%

29

Hybrid 33%

23

No Guarantees 25%

17

Other Platform Open

Domain 85%

35

Public 20%

8

Institution 12%

5

Other Internet 12%

5

Preprint 7%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
34
Europe PMC
Domain
23
Semantic Scholar
Public
8
DOI
Other Internet
4
University of Oxford - Oxford University Research Archive (ORA)
Institution
2
University Computing Centre - Hrčak Portal of scientific journals of Croatia
Other Internet
2
University College London - UCL Discovery
Institution
2
Preprints
Preprint
2
Unknown Repository
Other Internet
1
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI
Institution
1
1 / 2

Data updated 7 April 2025

Share

Share

Share